There's also evidence that GLP-1 agonists, like semaglutide and tirzepatide sold as Mounjaro, Ozempic, Wegovy and Zepound lower the risk of cardiovascular diseases protect the kidney and the liver, reduce inflammation and pain, prevent addiction and substance abuse, help people with arthritis and those with sleep apnea
Providers increase the dose when one of three conditions is met: the side effects at the current dose have become manageable, weight loss has plateaued below the patients goal, or enough time has passed under the titration protocol to safely advance
Alcohol can affect your blood sugar levels and add extra calories, which may work against your weight loss goals
On the epigenetic regulation of the human reelin promoter
This dual action may explain why tirzepatide has shown particularly strong results in clinical trials for both diabetes management and weight loss
Essential actions of melatonin in protecting the ovary from oxidative damage